Table of Contents Table of Contents
Previous Page  149 / 812 Next Page
Information
Show Menu
Previous Page 149 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348

S145

EW85

Mental health transition plans for

older adolescents with autistic

spectrum disorders – clinical profile

of patients from a metropolitan

Borough, North West of England

S. Olety

Pennine Care NHS Foundation Trust, Child and Adolescent Psychiatry,

Rochdale, United Kingdom

Introduction

The needs of people with Autistic Spectrum Condi-

tions (ASC) are varied and complex. In order to improve outcomes

for Adults with Autism, it is important to understand and evaluate

the transition planning process and current services for adoles-

cents/young Adults with ASC.

Aims and objectives

Aim was to undertake the needs assess-

ment audit of all young people (ages 16–19) open to a Child and

Adolescent Mental Health Service. Objectives was to ensure that

transition/discharge plan was in place for all the open cases and

also identify any gaps in service provision.

Methods

A retrospective case-note review of all open cases

(

n

= 41) aged 16–19 was undertaken. Data was obtained on

diagnosis, co morbid problems, educational status, and transi-

tion/discharge plans.

Results

Twenty-two percent of the cases had comorbidmoderate

to severe Intellectual Disability. Transition was not an issue for this

group, with entitlement of support from secondary-care-teams.

Seventy-eight percent of the cases had diagnosis of Asperger’s

Syndrome (AS)/high functioning autism (HFA). Seventy-five per-

cent had co-morbid depressive/anxiety disorders, 12% had ADHD

and 10% presented with repeated self-harm/suicidal behaviour.

Nature of the co-morbid problems/risks did not meet thresholds

for Community Adult Secondary Mental Health Services resulting

in discharge to Primary Health Care Services.

Conclusions

Better training to equip primary care staff, such as

General Practitioners is needed to support the growing numbers

of young adults with HFA/Asperger’s syndrome being discharged

to their care. Costs/benefits of providing specialist adult services

for people with HFA and AS to be considered in order to improve

outcomes for adults with autism.

Disclosure of interest

The author has not supplied his/her decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.203

EW86

Safeguarding foster care youth from

overmedication

C. Pataki

1 , 2 ,

, C. Thompson

1 , 3

, G. Crecelius

2

, J. Tesoro

2 , 4

,

G. Polsky

2

, P. Kambam

2

1

David Geffen School of Medicine at UCLA, Psychiatry &

Biobehavioral Science, Los Angeles, CA, USA

2

Los Angeles County Department of Mental Health, Juvenile Court

Mental Health Service, Monterey Park, CA, USA

3

Los Angeles County Department of Mental Health, Juvenile Justice

Mental Health Program, Los Angeles, CA, USA

4

University of Southern California School of Pharmacy, Pharmacy,

Los Angeles, CA, USA

Corresponding author.

Introduction

There are increasing concerns regarding long-term

psychotropic polypharmacy prescribed for foster care youth 3.5 to

5 times more often than in at-home youth (Kreider et al., 2014).

Polypharmacy risks include weight gain, glucose intolerance and

type 2 diabetes. (De Hert et al., 2011). In view of these risks, novel

interventions are essential to safeguard foster care youth from

overmedication.

Objectives

To present guidelines for identification and manage-

ment of polypharmacy in foster care youth.

Aims

To demonstrate a novel intervention tomonitor and dimin-

ish polypharmacy and enhance psychiatric care in foster care

children.

Methods

Polypharmacy is identified using LA County Juvenile

Court Mental Health Service (JCMHS) Psychotropic Parameters

*

to review medication consent forms from treating psychia-

trists. Polypharmacy triggers an in-person JCHMS consultation.

*

(Parameters 3.9 for JCMHS PMAF Review, Revised May 2015).

JCMHS Psychotropic Parameters (summary):

– age 0–5 years:

– 2 or > psychotropic medications,

– Any antipsychotic (

*

except Risperidone in ASD);

– age 6–8 years:

– 3 or > psychotropic medications;

– age 9–17 years:

– 4 or > psychotropic medications;

– All age youth:

– 2 or > psychotropic medications in the same class (antipsy-

chotics, antidepressants, stimulants, mood stabilizers, alpha

agonists).

Psychotropic medication doses in excess of recommended (

*

LA

County Department of Mental Health Parameters 3.8 for use of

Psychotropic Medications for Children and Adolescents).

Results

Approximately 25% of JCMHS annual psychiatric consul-

tations were initiated by JCMHS parameters for polypharmacy.

Corresponding consultations included education and recommen-

dations discussed with treating psychiatrists regarding polyphar-

macy and optimal psychiatric management.

Conclusions

JCMHS Psychotropic Parameters is a useful tool to

identify polypharmacy and enhance psychiatric care of foster care

youth.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.204

EW87

Clinical and psychopathological risk

factors for the development of

recurrent depression in children at

puberty

T. Proskurina

1 ,

, E. Mykhailova

1

, T. Matkovska

1

,

N. Reshetovska

1

, A. Matkovska

2

1

SI “Institute for Children and Adolescents Health Care of the NAMS

of Ukraine”, Psychiatry, Kharkov, Ukraine

2

Kharkiv V. Karazin National University Named, Medical Student,

Kharkov, Ukraine

Corresponding author.

Background and aims

The research is aimed at revealing clinical

and psychological predictors of recurrent depression in children.

Our study reflects the relationships of certain clinical and psycho-

logical markers in the development of recurrent depression (RD) in

children at the stage of sexual maturation.

Materials and methods

The study included 145 children in pre-

puberty and 200 children in puberty with recurrent depression,

in which manifestation of the first depressive episode occurred at

the age of 7–11 years. The study design included: social, clinical,

psychopathological, anamnestic, somatoneurological and neuro-

psychological monitoring (CDRS-R; MADRS; the Columbia-Suicide

Severity Rating Scale (C-SSRS), Toulouse-Pieronne test to deter-

mine the presence and type of a minimal brain dysfunction, as well

as Luria’s Memorizing 10 words technique).

Results

Analysis of the relationships between psychological

trauma factors, which took place in children at the stage of the

first depressive episode, and the risk of the recurrent depression

development in children at puberty has established the significance

of: school bullying (

r

= 0.13), combination of stress events (

r

= 0.11),

father flight (

r

= 0.10), lack of authority and environmental rejection